Detalles de la búsqueda
1.
A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαß+ and CD19+ Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome.
Biol Blood Marrow Transplant
; 24(7): 1432-1440, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550630
2.
Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.
Transplant Cell Ther
; 29(2): 127.e1-127.e9, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436779
Resultados
1 -
2
de 2
1
Próxima >
>>